{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:40:47Z","timestamp":1784292047146,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is one of the most common primary cancers with limited therapeutic options. Melatonin, a neuroendocrine hormone produced primarily by the pineal gland, demonstrates an anti-cancer effect on a myriad of cancers including HCC. However, whether melatonin could suppress tumor growth through regulating RNA alternative splicing remains largely unknown. Here we demonstrated that melatonin could inhibit the growth of HCC. Mechanistically, melatonin induced transcriptional alterations of genes, which are involved in DNA replication, DNA metabolic process, DNA repair, response to wounding, steroid metabolic process, and extracellular matrix functions. Importantly, melatonin controlled numerous cancer-related RNA alternative splicing events, regulating mitotic cell cycle, microtubule-based process, kinase activity, DNA metabolic process, GTPase regulator activity functions. The regulatory effect of melatonin on alternative splicing is partially mediated by melatonin receptor MT1. Specifically, melatonin regulates the splicing of <jats:italic>IKBKG<\/jats:italic> (NEMO), an essential modulator of NF-\u03baB. In brief, melatonin increased the production of the long isoform of NEMO-L with exon 5 inclusion, thereby inhibiting the growth of HepG2 cells. Collectively, our study provides a novel mechanism of melatonin in regulating RNA alternative splicing, and offers a new perspective for melatonin in the inhibition of cancer progression.<\/jats:p>","DOI":"10.3389\/fphar.2022.1007006","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T05:15:05Z","timestamp":1664169305000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO"],"prefix":"10.3389","volume":"13","author":[{"given":"Lu","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.humpath.2011.08.009","article-title":"NEMO expression in human hepatocellular carcinoma and its association with clinical outcome","volume":"43","author":"Aigelsreiter","year":"2012","journal-title":"Hum. Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/387049a0","article-title":"Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression","volume":"387","author":"Alland","year":"1997","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/17425255.2016.1214712","article-title":"A review of the protective effect of melatonin in pesticide-induced toxicity","volume":"13","author":"Asghari","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","article-title":"Roles and mechanisms of alternative splicing in cancer - implications for care","volume":"17","author":"Bonnal","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ncb3062","article-title":"Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs","volume":"16","author":"Bowman","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1600-079X.2011.00910.x","article-title":"Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: Role of the MT1 receptor","volume":"51","author":"Carbajo-Pescador","year":"2011","journal-title":"J. Pineal Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1600-079X.2009.00719.x","article-title":"Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells","volume":"47","author":"Carbajo-Pescador","year":"2009","journal-title":"J. Pineal Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/hep.30500","article-title":"Long-read RNA sequencing identifies alternative splice variants in hepatocellular carcinoma and tumor-specific isoforms","volume":"70","author":"Chen","year":"2019","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e12755","DOI":"10.1111\/jpi.12755","article-title":"Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3\/PDH axis","volume":"71","author":"Chen","year":"2021","journal-title":"J. Pineal Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3892\/ol.2016.4605","article-title":"Effects of melatonin on HIF-1\u03b1 and VEGF expression and on the invasive properties of hepatocarcinoma cells.","volume":"12","author":"Colombo","year":"2016","journal-title":"Oncol. Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"E1088","DOI":"10.3390\/antiox9111088","article-title":"Is melatonin the cornucopia of the 21st century?","volume":"9","author":"Ferlazzo","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/antiox10010103","article-title":"Melatonin as an antitumor agent against liver cancer: An updated systematic review","volume":"10","author":"Fernandez-Palanca","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/hep.31062","article-title":"Splicing regulator p54(nrb)\/Non-POU domain-containing octamer-binding protein enhances carcinogenesis through oncogenic isoform switch of MYC box-dependent interacting protein 1 in hepatocellular carcinoma","volume":"72","author":"Hu","year":"2020","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/cells10040923","article-title":"Regulation of RNA splicing: Aberrant splicing regulation and therapeutic targets in cancer","volume":"2021","author":"Kitamura","year":"2021","journal-title":"Cells"},{"key":"B16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/imr.12550","article-title":"The interplay of IKK, NF-\u03baB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation.","volume":"277","author":"Kondylis","year":"2017","journal-title":"Immunol. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ccell.2015.10.001","article-title":"NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis","volume":"28","author":"Kondylis","year":"2015","journal-title":"Cancer Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1600-079X.2008.00635.x","article-title":"Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line","volume":"46","author":"Korkmaz","year":"2009","journal-title":"J. Pineal Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: A therapeutic perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1634\/theoncologist.2019-IO-S1-s01","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: Opportunities and challenges","volume":"24","author":"Liu","year":"2019","journal-title":"Oncologist"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","article-title":"Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma","volume":"11","author":"Luedde","year":"2007","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1600-079X.2010.00781.x","article-title":"In vitro and in vivo antitumor activity of melatonin receptor agonists","volume":"49","author":"Mao","year":"2010","journal-title":"J. Pineal Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12391","DOI":"10.1111\/jpi.12391","article-title":"Melatonin and sirtuins: A \"not-so unexpected\" relationship","volume":"62","author":"Mayo","year":"2017","journal-title":"J. Pineal Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.3748\/wjg.v22.i27.6114","article-title":"Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?","volume":"22","author":"Montella","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1053\/j.gastro.2019.01.247","article-title":"CXCR6 inhibits hepatocarcinogenesis by promoting natural killer T- and CD4(+) T-cell-dependent control of senescence","volume":"156","author":"Mossanen","year":"2019","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100728","DOI":"10.1016\/j.drup.2020.100728","article-title":"The role of alternative splicing in cancer: From oncogenesis to drug resistance","volume":"53","author":"Sciarrillo","year":"2020","journal-title":"Drug resist. updat."},{"key":"B29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhep.2007.05.006","article-title":"The role of NF-kappaB in hepatocarcinogenesis: Promoter or suppressor?","volume":"47","author":"Seki","year":"2007","journal-title":"J. Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca. A Cancer J. Clin."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/molecules26092506","article-title":"Melatonin in cancer treatment: Current knowledge and future opportunities","volume":"26","author":"Talib","year":"2021","journal-title":"Molecules"},{"key":"B32","doi-asserted-by":"publisher","first-page":"E518","DOI":"10.3390\/molecules23030518","article-title":"Melatonin and cancer hallmarks","volume":"2018","author":"Talib","year":"2018","journal-title":"Molecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.trecan.2020.04.011","article-title":"RNA splicing and cancer","volume":"6","author":"Wang","year":"2020","journal-title":"Trends Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccr.2014.07.010","article-title":"The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression","volume":"26","author":"Wang","year":"2014","journal-title":"Cancer Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ncb3538","article-title":"The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1","volume":"19","author":"Yuan","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fendo.2019.00249","article-title":"Melatonin Synthesis and function: Evolutionary history in animals and plants","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Endocrinol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1007006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T05:15:08Z","timestamp":1664169308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1007006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":38,"alternative-id":["10.3389\/fphar.2022.1007006"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1007006","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"article-number":"1007006"}}